Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Refills vs VyrarX

Refills
Graded #443

Lower grade

vs+13.099999999999994
VyrarX
Graded #156

Higher grade

The verdict

VyrarX takes it — 68.3/100 to 55.2/100.

VyrarX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVyrarX +15
45
60
Dose & formulationVyrarX +24
40
64
Clinical oversightVyrarX +8
76
84
Labs & monitoringVyrarX +20
52
72
FulfillmentEven
71
71
Contract termsEven
55
55
Refills · left barVyrarX · right bar

The numbers

MetricRefillsVyrarX
WeighScore55.2/10068.3/100
GradeCC
Scorecard rank#443#156
SemaglutideNot disclosed$179/mo (starting dose, compounded)
TirzepatideNot disclosed$329/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Refills

Graded #443 · C

Strengths

  • LegitScript Certified online pharmacy
  • Claims operation across all 50 states (with some exclusions)
  • Multi-category platform (weight loss + ED + hair growth + wellness) — single account for multiple treatments
  • Free shipping disclosed publicly
  • Cash-pay, no insurance needed

Where it loses points

  • Ongoing monthly pricing for compounded semaglutide and tirzepatide not shown until after intake
  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy partner not named
  • Excluded states not listed in marketing copy — verify coverage during intake
  • Compounded only — no brand-name GLP-1 (Wegovy, Zepbound, Mounjaro, Ozempic, Foundayo)
VyrarX

Graded #156 · C

Strengths

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Where it loses points

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard